MNX Market Network Exchange
Commercial intelligence · New York
Menu
MarketAwardsContracts and grants already awardedOpportunitiesRFPs and grants open nowPolicyBills, laws, and regulationsProgramsNamed funding initiatives and who they fundCalendarUpcoming committee hearings and meetings
NetworkOfficialsEveryone holding public office in New York City and StateOrganizationsPublic and civic sector organizations across New YorkLobbyingWho is registered to lobby, for which client, and for how much
ExchangeMarket structureWho funds a sector, how concentrated it is, and who is establishedStakeholder mapThe offices whose remit intersects your work, mapped to your siteLobbying landscapeWho is already lobbying your space, the most-lobbied offices, and what representation costsDossiersOne reconciled file on any organization, agency, or officialMonitorAlerts on new money, RFPs, and mentions you trackBuild a PlanA strategic plan customized for you
AboutHire a consultant ↗
Sign inGet Pro
Build my strategy
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

New York funding

AI-driven Structure-enabled Antiviral Platform (ASAP)

$21.6M

ShareLinkedIn ↗Email
Funder
National Institute of Allergy and Infectious Diseases
Amount
$21.6M
Recipient
Sloan-kettering Inst Can Research
Deadline
Through December 31, 2027

Purpose

National Institute of Allergy and Infectious Diseases awarded $21.6M to Sloan-kettering Inst Can Research (PI John Damon Chodera) for AI-driven Structure-enabled Antiviral Platform (ASAP). Biomedical and health research. Location: NY.

federalnihgranthealthny

Official source ↗

Free account

Create a free account

Track New York funding and save searches across the Network. Free. No card required.

Want to reach the funders and organizations active in your market? Build your Market Network Strategic Plan →